Trial
NCT04377945
Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bukwang Pharmaceutical
Collaborators
—
Condition
Dyskinesias
Intervention
Part 1, JM-010 component Group A
Why stopped
Business reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-17